The Board shall inspect pharmacies located in Maryland at least annually. The pharmacy shall provide as part of the inspection process: Quality assurance testing reports; Documentation of reporting adverse events as required in Regulation .18 of this chapter; Microbial testing of a sampling of the sterile compounded preparations of the pharmacy if applicable according to USP 797 Standards; and Any other information requested to ensure compliance with USP 797 Standards. Within 90 days before the date of application, inspections of nonresident pharmacies may be conducted by: A designee of the Board; The U.S. Food and Drug Administration; or Another appropriate state entity which indicates compliance with USP 797 Standards. The Board or designee shall inspect nonresident pharmacies upon initial application and upon renewal. The Board may inspect a pharmacy at any time to: Verify compliance with permit requirements; or Investigate a complaint.